Lung Cheung News Today

On April 18, at a seminar on Hong Kong’s national security education, some teachers asked whether it would ...

The use of SGLT2 inhibitors with type 2 diabetes is associated with lower risks for end-stage renal disease and acute renal failure compared with DPP-IV inhibitor use, according to study findings from Hong Kong. “DPP-IV inhibitors and SGLT2 inhibitors are commonly used second-line antidiabetic medications,” Ching-Lung Cheung, PhD, associate professor in the department of pharmacology